Jointly sponsored by the University of Cincinnati and Princeton CME
Target Audience
This activity is designed for primary care physicians, nurse practitioners, and physician assistants.
Learning Objectives
After completing this activity, participants should be able to:
- Summarize the clinical and economic burden of chronic, noncancer pain on patients and the US healthcare system
- Identify common types of chronic, noncancer pain and assess for severity
- Outline multimodal approaches for chronic, noncancer pain management
- Put into practice patient-centered methods for initiation, maintenance, and termination of opioid therapy
- Describe the role of pain specialists and clinics in chronic, noncancer pain management
Credit Eligibility
To be eligible for documentation of credit, participants must participate in the full educational activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.
Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.
Release date: December 28, 2007; Expiration date: February 5, 2009
Estimated time to complete: 1 hour
There is no fee associated with this activity.
Lecture Components
The presentation slides, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.
This activity is made available online and in print.
CME Accreditation (Accepted for Physician Assistants)
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Cincinnati and Princeton CME. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AANP Accreditation
This program has been approved for 1.0 contact hour of continuing education by the American Academy of Nurse Practitioners. Program ID 0710468.
Grant Support
Supported by an unrestricted educational grant from King Pharmaceuticals, Inc.
Participating Faculty
Presenters
Ellen Battista, DNS, ANP, PNP
Pain Treatment Consultants of Western New York
Williamsville, New York
Howard A. Heit, MD, FACP, FASAM
Assistant Clinical Professor
Georgetown University School of Medicine
Washington, DC
Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health and Family Medicine
University of Florida
Gainesville, Florida
Charles A. Moxin, MPAS, PA-C
Immediate Past President
Association of Family Practice
Physician Assistants (AFPPA)
San Antonio, Texas
Independent Clinical Reviewers
Doris K. Cope, MD
Professor and Vice Chairman
Department of Anesthesiology
Division of Pain Medicine
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
Christopher Gharibo, MD
Clinical Director of Pain Medicine
Assistant Professor of Anesthesiology
New York University Medical Center
New York, New York
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of the University of Cincinnati and Princeton CME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of the University of Cincinnati and Princeton CME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The faculty has reported the following:
Dr. Battista: Consultant—Alpharma, Inc, Endo Pharmaceuticals, King Pharmaceuticals, Inc; Speaker’s bureau—Alpharma, Inc
Dr. Gharibo: Speaker’s bureau—Endo Pharmaceuticals, Pfizer, Inc
Dr. Heit: Consultant—Alpharma, Inc, Cephalon, Endo Pharmaceuticals, King Pharmaceuticals, Inc, Purdue Pharma, LP
Dr. Kuritzky: Speaker’s bureau—Bayer, Boehringer-Ingelheim, Endo Pharmaceuticals
Mr. Moxin: Consultant—Abbott, Bristol-Myers Squibb, Endo Pharmaceuticals, Roche Pharmaceuticals, Wyeth Pharmaceuticals; Speaker’s bureau—Bristol-Myers Squibb, Endo Pharmaceuticals, GlaxoSmithKline, McNeil Pharmaceuticals, Oscient Pharmaceuticals, Pfizer, Inc
Dr. Cope disclosed no relevant financial relationships with any commercial interests.
Planning Committee Kay Weigand, University of Cincinnati; Randy Robbin and John Savage, Princeton CME; Jessica Brown, Kristin Dickie, Rosemary Hodgson, and Mary Johnson, Princeton Media Communications have disclosed no relevant financial relationships with any commercial interests.
Off-label Disclosure
The University of Cincinnati and Princeton CME require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.
The following off-label/unapproved drugs or devices are discussed: sublingual buprenorphine, antidepressant and antiepileptic agents, and clonidine in the treatment of chronic pain.
Some of the clinical studies discussed in this activity may have been funded by manufacturers of drugs or devices.